Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) EBT: 2024-2025

Historic EBT for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$22.0 million.

  • Pyxis Oncology's EBT fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$102.6 million, marking a year-over-year change of. This contributed to the annual value of -$79.5 million for FY2024, which is 7.73% down from last year.
  • As of Q3 2025, Pyxis Oncology's EBT stood at -$22.0 million, which was down 3.99% from -$21.2 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year EBT high stood at -$3.3 million for Q2 2024, and its period low was -$37.7 million during Q4 2024.
  • Its 2-year average for EBT is -$18.7 million, with a median of -$21.2 million in 2024.
  • Data for Pyxis Oncology's EBT shows a maximum YoY tumbled of 549.82% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's EBT (Quarterly) stood at -$37.7 million in 2024, then fell by 3.77% to -$22.0 million in 2025.
  • Its EBT stands at -$22.0 million for Q3 2025, versus -$21.2 million for Q2 2025 and -$21.7 million for Q1 2025.